Title:
HUMAN INTERLEUKIN-2 VARIANT AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/005680
Kind Code:
A1
Abstract:
Provided are a human interleukin-2 variant and the use thereof. Specifically, provided is an IL-2 variant (or a derivative thereof) having eliminated or reduced affinity with a high-affinity receptor IL-2Rα/β/γ and retaining affinity with a medium-affinity receptor IL-2Rβ/γ. Also provided is a recombinant protein/fusion protein comprising an IL-2 variant and a human antibody fragment. The activity of the IL-2 variant is improved, and is close to the activity of a wild human IL-2.
More Like This:
Inventors:
DONG MINGHUI (CN)
LU YONGTAO (CN)
LIU JIANGUANG (CN)
LU YONGTAO (CN)
LIU JIANGUANG (CN)
Application Number:
PCT/CN2022/105789
Publication Date:
February 02, 2023
Filing Date:
July 14, 2022
Export Citation:
Assignee:
XIAN LONGTENGJINGYUN BIOTECHNOLOGY CO LTD (CN)
YUNQUAN BIOTECHNOLOGY BEIJING CO LTD (CN)
YUNQUAN BIOTECHNOLOGY BEIJING CO LTD (CN)
International Classes:
C07K14/55; A61K38/20; A61K47/68; A61P35/00; A61P37/00; C07K19/00; C12N15/62; C12N15/64; C12N15/70; C12N15/81
Domestic Patent References:
WO2020125743A1 | 2020-06-25 | |||
WO2009135615A2 | 2009-11-12 | |||
WO2012062228A2 | 2012-05-18 |
Foreign References:
CN114369153A | 2022-04-19 | |||
CN111647068A | 2020-09-11 | |||
CN113831402A | 2021-12-24 | |||
CN112105633A | 2020-12-18 | |||
CN104231068A | 2014-12-24 | |||
CN202110868409A | 2021-07-30 | |||
CN202210621425A | 2022-06-01 | |||
US8906356B2 | 2014-12-09 | |||
US9732134B2 | 2017-08-15 | |||
US7803361B2 | 2010-09-28 | |||
US8124066B2 | 2012-02-28 |
Other References:
CHANG RUIXUE, YAN TIAN-HUA, WANG QIU-JUAN, GUO QING-LONG: "Advances in Application of Interleukin-2 and Its Related Drugs ", PROGRESS IN PHARMACEUTICAL SCIENCES, CHINA PHARMACEUTICAL UNIVERSITY, CN, vol. 35, no. 1, 25 January 2011 (2011-01-25), CN , pages 1 - 7, XP093028922, ISSN: 1001-5094, DOI: 10.3969/j.issn.1001-5094.2011.01.001
"Genbank", Database accession no. NP_000577.2
"Genbank", Database accession no. NP_000577.2
Attorney, Agent or Firm:
GE CHENG & CO., LTD (CN)
Download PDF: